Search Results - "WOODRUFF, M"
-
1
Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth
Published in The Journal of immunology (1950) (15-04-2015)“…The complement activation product C3a is often described as a proinflammatory mediator, alongside its downstream cousin, C5a. However, emerging studies show…”
Get full text
Journal Article -
2
Electrospraying of polymers with therapeutic molecules: State of the art
Published in Progress in polymer science (01-11-2012)“…The encapsulation and release of bioactive molecules from polymeric vehicles represents the holy grail of drug and growth factor delivery therapies, whereby…”
Get full text
Journal Article -
3
Complement dysregulation in the central nervous system during development and disease
Published in Seminars in immunology (01-10-2019)“…•Complement proteins play essential roles in brain development.•Complement signalling can both protect against and aggravate neurological disease.•Complement…”
Get full text
Journal Article -
4
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Published in The Journal of immunology (1950) (15-06-2019)“…Complement activation generates the core effector protein C5a, a potent immune molecule that is linked to multiple inflammatory diseases. Two C5a receptors,…”
Get full text
Journal Article -
5
New tricks for an ancient system: Physiological and pathological roles of complement in the CNS
Published in Molecular immunology (01-10-2018)“…•Complement has critical functional roles in embryonic brain development.•C1, C4, C2, C3 and CR3 are critical in synaptic refinement during brain…”
Get full text
Journal Article -
6
C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages
Published in The Journal of immunology (1950) (15-08-2020)“…The complement activation fragment C5a is a potent proinflammatory mediator that is increasingly recognized as an immune modulator. C5a acts through two C5a…”
Get full text
Journal Article -
7
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Published in Glia (01-02-2020)“…Microglial NLRP3 inflammasome activation is emerging as a key contributor to neuroinflammation during neurodegeneration. Pathogenic protein aggregates such as…”
Get full text
Journal Article -
8
Developmental activities of the complement pathway in migrating neurons
Published in Nature communications (02-05-2017)“…In recent years the notion that malfunctioning of the immune system may result in developmental brain diseases has emerged. However, the role of immune…”
Get full text
Journal Article -
9
Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment
Published in Brain (London, England : 1878) (01-02-2010)“…Traumatic injury to the central nervous system results in the disruption of the blood brain/spinal barrier, followed by the invasion of cells and other…”
Get full text
Journal Article -
10
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
Published in Molecular neurodegeneration (25-01-2011)“…Stroke is the world's second leading cause of mortality, with a high incidence of severe morbidity in surviving victims. There are currently relatively few…”
Get full text
Journal Article -
11
The Peripheral Immune System and Amyotrophic Lateral Sclerosis
Published in Frontiers in neurology (21-04-2020)“…Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease that is defined by loss of upper and lower motor neurons, associated with…”
Get full text
Journal Article -
12
A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models
Published in Journal of neurochemistry (01-08-2021)“…The blood–brain barrier (BBB) and blood–spinal cord barrier (BSCB) are highly specialized structures that limit molecule entry from the blood and maintain…”
Get full text
Journal Article -
13
C5L2: a controversial receptor of complement anaphylatoxin, C5a
Published in The FASEB journal (01-03-2013)“…C5a is the paramount proinflammatory mediator of the complement cascade, and has been previously thought to act only through a single, G‐protein‐coupled, C5a…”
Get full text
Journal Article -
14
Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors
Published in Scientific reports (24-11-2022)“…Despite increasing knowledge about the factors involved in the progression of diabetic complications, diabetic kidney disease (DKD) continues to be a major…”
Get full text
Journal Article -
15
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Published in Nature communications (05-10-2016)“…Prokineticin-2 (PK2), a recently discovered secreted protein, regulates important physiological functions including olfactory biogenesis and circadian rhythms…”
Get full text
Journal Article -
16
Revisiting the role of the innate immune complement system in ALS
Published in Neurobiology of disease (01-07-2019)“…Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing motor neuron disease without effective treatment. Although the precise mechanisms…”
Get full text
Journal Article -
17
Biomimetic tubular nanofiber mesh and platelet rich plasma-mediated delivery of BMP-7 for large bone defect regeneration
Published in Cell and tissue research (01-03-2012)“…There is a growing need for successful bone tissue engineering strategies and advanced biomaterials that mimic the structure and function of native tissues…”
Get full text
Journal Article -
18
The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury
Published in The Journal of neuroscience (22-04-2015)“…This study investigated the role of the complement activation fragment C5a in secondary pathology following contusive spinal cord injury (SCI). C5ar(-/-) mice,…”
Get full text
Journal Article -
19
C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis
Published in Kidney international (01-03-2018)“…The prospects for complement-targeted therapy in ANCA-associated vasculitis have been enhanced by a recent clinical trial in which C5a receptor 1 (C5aR1)…”
Get more information
Journal Article -
20
Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration
Published in The Journal of immunology (1950) (15-11-2020)“…Neutrophil infiltration to ischemic tissues following reperfusion worsens injury. A key driver of neutrophil recruitment and activation is the complement…”
Get full text
Journal Article